TEXARCANA, Tex. — Pharma Nobis, a leading provider of innovative pharmaceutical and over-the-counter solutions, today announced the appointment of Tim Buskey as President and Chief Executive Officer, effective October 6, 2025. Buskey succeeds Frank Harmon, who will transition into the role of Executive Chairman of the Board.
Buskey has over 33 years of experience leading commercial strategy and sales in pharma and healthcare. He was most recently Chief Commercial Officer at Strides Pharma, and has held senior roles at Intuity Medical, PharmaCline, Inc., and AmerisourceBergen.
With extensive expertise in the over-the-counter (OTC) sector, Buskey has collaborated with major U.S. retailers, including CVS, Walmart, Walgreens, and Dollar General, and has a proven record of building strong partnerships across the retail pharmaceutical landscape.
“I am honored to join Pharma Nobis and look forward to working with the team to strengthen our market presence and expand the company’s impact,” said Buskey. “Pharma Nobis has a strong reputation for quality and innovation, and I am excited to build on that legacy.”
Frank Harmon, Executive Chairman of the Board, stated: “We are delighted to welcome Tim to Pharma Nobis. His deep experience, particularly in the OTC market, will help guide the company through its next phase of growth and success.”
